Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2010
10/20/2010CN101862417A Natural spraying agent (dew) preventing and treating sneezing and snivel
10/20/2010CN101862410A Chinese medicinal preparation for treating chronic pharyngitis
10/20/2010CN101862409A Chinese medicament for treating wind-chill cold
10/20/2010CN101862406A Schizonepeta and saposhnikovia decoction for treating chronic sinusitis
10/20/2010CN101862383A Processing method of loquat flowers
10/20/2010CN101862373A Quality control method for mulberry chrysanthemum granules
10/20/2010CN101862359A Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof
10/20/2010CN101862358A Acute turpinia leaf ethanol percolation extract, and preparation method and application thereof
10/20/2010CN101862357A Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof
10/20/2010CN101862353A Method for extracting total triterpenes in fungus larch
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862330A Bicyclic amide derivatives for the treatmet of respiratory disorders
10/20/2010CN101862318A Combined medicament-combined linolenic acid capable of preventing and fundamentally treating thromboembolic diseases
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862305A Ambroxol hydrochloride sustained-release pellet and preparation method
10/20/2010CN101862298A Benproperine phosphate granular formulation
10/20/2010CN101361983B Lung cancer DNA plasmid vaccine and preparation method thereof
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816374 Administering to respiratory system an effective amount of a topical anesthetic, such as lidocaine, or a pharmaceutically acceptable salt thereof; chronic obstructive pulmonary disease
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2456547C Process for preparing inhalable powders
10/19/2010CA2427282C Mixtures or organic compounds for the treatment of airway diseases
10/19/2010CA2409743C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/19/2010CA2321455C Indole-3-propionic acids, salts and esters thereof used as medicaments
10/19/2010CA2177249C Abundant extracellular products and methods for their production and use
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010116127A1 Combination of cetirizine and mefenamic acid for the treatment of exacerbations of asthma
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010075086A3 Pyrrolidinone inhibitors of pde-4
10/14/2010WO2010066912A4 Compounds having activity in correcting mutant cftr cellular processing
10/14/2010US20100261780 Highly Acidic Chitosan-Nucleic Acid Polyplex Compositions
10/14/2010US20100261779 Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261705 Carbostyril compound
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261690 Novel combinations
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260853 Compositions for pulmonary delivery
10/14/2010US20100260842 Pseudoephedrine pharmaceutical formulations
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260788 Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
10/14/2010US20100260779 Methods and molecules for modulating an immune response
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260763 Polypeptides, antibody variable domains and antagonists methods for
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260744 Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor
10/14/2010US20100260725 Materials and Methods for Treating Allergic and Inflammatory Conditions
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010CA2754343A1 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis
10/13/2010EP2239325A1 Virus growing in hypoxic cell or virus vector expressing gene therein
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/13/2010EP2237788A2 Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1931258B Preparation process and use of loquat seed extract
10/13/2010CN1799586B Cold treating capsule and its preparation method
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861319A Benzazepinone compound
10/13/2010CN101861314A Xinafoate salt of N4-[(2, 2-difluoro-4N-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
10/13/2010CN101856488A Chinese medicament for treating tracheitis
10/13/2010CN101856465A Chinese medicinal beverage for clearing heat, preventing heatstroke and improving eyesight and preparation method thereof
10/13/2010CN101856459A Chinese medicinal composition for treating lung carbunculosis and preparation method thereof
10/13/2010CN101856453A Nanomedicine composition for resisting primary bronchitis virus and preparation method thereof
10/13/2010CN101856452A Medicament for treating bronchitis and preparation method thereof
10/13/2010CN101856443A Method for preparing Chinese patent medicament arisaema cum bile
10/13/2010CN101856438A Medicinal composition for treating infant asthma and preparation method and use thereof
10/13/2010CN101856427A Method for extracting solanine from potato peels
10/13/2010CN101856424A Chinese medicament for treating chronic pharyngitis
10/13/2010CN101856415A Chinese herbal medicament oral liquid for treating chicken respiratory infectious disease
10/13/2010CN101856382A Novel method for extracting and separating platycodin effective ingredients
10/13/2010CN101856362A Pharmaceutical compositions for the treatment of asthma
10/13/2010CN101856345A Powder manufacturing method suitable for inhalation-type drug administration
10/13/2010CN101856334A Asarin composite freeze-dried powder for injection
10/13/2010CN101856333A Freeze-dried powder injection of cefamandole nafate and preparation method thereof
10/13/2010CN101856327A Aerosol with quantitative inhalation of bencycloquidium bromide and preparation method thereof
10/13/2010CN101385848B Medicine for treating bronchitis
10/13/2010CN101380436B Traditional Chinese medicine composition for treating chronic pharyngitis
10/13/2010CN101361895B Traditional Chinese medicine combination for treating measles complicated pneumonia
10/13/2010CN101336673B Water ice formulation capable of arresting blood after tonsil operation
10/13/2010CN101317847B Medicament composition for eyes or nose, and uses thereof
10/13/2010CN101199810B Chinese medicine preparation for treating spleen deficient disunify epistaxis